Inmune Bio (INMB) Capital Expenditures (2025)
Inmune Bio (INMB) posted Capital Expenditures of $143,000 for Q4 2025, down 25.9% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Capital Expenditures (2025) Analysis & Trends
For FY2025, Inmune Bio's Capital Expenditures came in at $1.04 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.90 Bn | 1,105.48 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 617.06 Bn | 535.59 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 501.38 Bn | 474.49 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.31 Bn | 235.00 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 236.29 Bn | 191.69 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 190.40 Bn | 164.60 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 169.55 Bn | 116.19 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Inmune Bio | 43.68 Mn | -48.57 Mn | - | - |
API Access
Inmune Bio Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();